BioLineRx (BLRX) Tops Q1 EPS by 62c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to BioLineRx (BLRX) Tops Q1 EPS by 62c

BioLineRx Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 20, 2020 7:00 AM EDT

TEL AVIV, Israel, May 20, 2020 /PRNewswire/ --  BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a late clinical-stage biopharmaceutical company focused on oncology, today reports its financial results for the quarter ended March 31, 2020 and provides a corporate update.

Highlights and achievements during the first quarter 2020 and subsequent period:

Completed recruitment of the triple combination arm of the COMBAT/KEYNOTE-202 study; Continued to advance the COMBAT/KEYNOTE-202 study toward progression free survival (PFS) and overall survival (OS) data in mid-2020;... More